If your doctor refuses to renew your prescription for Entocort (budesonide) even though you feel that you need to continue using it, show her or him this study:
One Year of Low-Dose Budesonide Safe, Effective for Collagenous ColitisThe new study began with an eight-week open-label induction period in which 110 patients received 9 milligrams of oral budesonide, tapered to 4.5 milligrams daily. Dr Falk Pharma GmbH, whose brand Budenofalk was used in the trial, funded the research.
Patients who achieved clinical remission were then randomly assigned to 4.5 milligrams a day of budesonide or placebo for an additional 52 weeks, followed by a six-month treatment-free follow-up. Because the drug only comes in 3 milligram capsules, patients alternated between taking one and two capsules a day.
During the open-label phase, 93 of the 110 patients enrolled achieved remission, with a median time to remission of 10.5 days. At one year, 61.4% of the patients on budesonide were still in remission, versus 16.7% of the placebo group (p<0.001).
Or, if you don't want to register at Medscape in order to read the article, here's the link that you can give to your doctor. Medscape is universally respected by medical professionals, so your doctor shouldn't argue about this one.
http://www.medscape.com/viewarticle/835749
Tex